氰戊菊酯在入市发展中形成复配制剂为主体。据统计至2002年全国有290家企业登记复配制剂395个厂次(其中33家企业兼登记单剂生产)。与溴氰菊酯、高效氯氰菊酯、氯氰菊酯复配制剂登记数比较,分别为该3个品种的572%、119%和144%。在相关品种组合复配中,马拉硫磷、辛硫磷、氧化乐果、乐果、水胺硫磷5个有机磷品种主要与氰戊菊酯复配。马拉硫磷与氰戊菊酯复配是第二组 Fenvalerate into the market in the formation of complex formulations as the main body. According to statistics, in 2002, there were 290 enterprises in the country registering 395 factories (of which 33 enterprises and single-dose registrations). Compared with the registration numbers of deltamethrin, beta-cypermethrin and cypermethrin formulations, they were 572%, 119% and 144% of the three varieties, respectively. In the combination of the relevant varieties and combinations, malathion, phoxim, omethoate, dimethoate, ammonia parathion 5 organic phosphorus species and fenvalerate complex. Malathion and fenvalerate complex is the second group